90 related articles for article (PubMed ID: 24436278)
1. Double minutes and MYC amplification: a combined May-Grunwald Giemsa and fluorescence in situ hybridization study.
Wong KF; Siu LL; Wong WS
Am J Clin Pathol; 2014 Feb; 141(2):280-4. PubMed ID: 24436278
[TBL] [Abstract][Full Text] [Related]
2. MYC is not overexpressed in a case of chronic myelomonocytic leukemia with MYC-containing double minutes.
Paulsson K; Lassen C; Kuric N; Billström R; Fioretos T; Tanke HJ; Johansson B
Leukemia; 2003 Apr; 17(4):813-5. PubMed ID: 12682646
[No Abstract] [Full Text] [Related]
3. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.
Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I
Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658
[TBL] [Abstract][Full Text] [Related]
4. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
[TBL] [Abstract][Full Text] [Related]
5. Unusual intracytoplasmic crystalline inclusions in chronic myelomonocytic leukemia with double minute chromosomes and MYC amplification: a rare case.
Miyazaki K; Suzuki K
Acta Haematol; 2014; 132(1):68-72. PubMed ID: 24481037
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia with MYC amplification in the homogeneous staining regions and double minutes.
Lee S; Kim M; Lim J; Kim Y; Han K; Kim HJ; Cho SG; Min WS
Cancer Genet Cytogenet; 2009 Jul; 192(2):96-8. PubMed ID: 19596264
[No Abstract] [Full Text] [Related]
7. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
[TBL] [Abstract][Full Text] [Related]
8. MYC gene amplification in double minute chromosomes in an aggressive large B-cell lymphoma with leukemic presentation: a case report.
Alseraye F; Padmore R; Wozniak M; McGowan-Jordan J
Cancer Genet Cytogenet; 2009 Jul; 192(2):76-8. PubMed ID: 19596258
[TBL] [Abstract][Full Text] [Related]
9. New insights into the biology of multiple myeloma using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level.
Nickenig C; Lang NK; Schoch C; Hiddemann W; Haferlach T
Ann Hematol; 2001 Nov; 80(11):662-8. PubMed ID: 11757725
[TBL] [Abstract][Full Text] [Related]
10. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
[TBL] [Abstract][Full Text] [Related]
11. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array.
Rummukainen JK; Salminen T; Lundin J; Kytölä S; Joensuu H; Isola JJ
Mod Pathol; 2001 Oct; 14(10):1030-5. PubMed ID: 11598174
[TBL] [Abstract][Full Text] [Related]
12. Gene amplification in myeloid leukemias elucidated by fluorescence in situ hybridization.
Rayeroux KC; Campbell LJ
Cancer Genet Cytogenet; 2009 Aug; 193(1):44-53. PubMed ID: 19602463
[TBL] [Abstract][Full Text] [Related]
13. c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance.
Schleger C; Verbeke C; Hildenbrand R; Zentgraf H; Bleyl U
Mod Pathol; 2002 Apr; 15(4):462-9. PubMed ID: 11950922
[TBL] [Abstract][Full Text] [Related]
14. Double minutes with MYC amplification in a patient with chronic myelomonocytic leukaemia transformed into acute myeloid leukaemia.
Deplano S; May PC; Pavlů J
Br J Haematol; 2013 Sep; 162(6):720. PubMed ID: 23862742
[No Abstract] [Full Text] [Related]
15. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.
Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y
Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657
[TBL] [Abstract][Full Text] [Related]
16. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
17. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G
Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525
[TBL] [Abstract][Full Text] [Related]
18. Pisosterol induces interphase arrest in HL60 cells with c-MYC amplification.
Silva TC; Lima PD; Bahia MO; Khayat AS; Bezerra FS; Andrade-Neto M; Seabra AD; Pontes TB; Moraes MO; Montenegro RC; Costa-Lotufo LV; Pessoa C; Pinto GR; Burbano RR
Hum Exp Toxicol; 2010 Mar; 29(3):235-40. PubMed ID: 20071475
[TBL] [Abstract][Full Text] [Related]
19. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
20. Frequent upregulation of MYC in plasma cell leukemia.
Chiecchio L; Dagrada GP; White HE; Towsend MR; Protheroe RK; Cheung KL; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
Genes Chromosomes Cancer; 2009 Jul; 48(7):624-36. PubMed ID: 19396865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
